Tuesday, 18 February 2014

FDA’s 21 CFR Part 11 Add-on Inspections

Scheduled On : Thursday, February 27, 2014 at 1 PM EST | 10 AM PST
Duration : 120 Minutes

 REGISTER NOW !

Description : 

In December 2010 the FDA began a project to better understand the industry’s adherence (or lack thereof) to 21 CFR Part 11. This involves the add on’ surveillance inspections of the sponsors’ computer systems during the course of the FDA’s regular inspections.

This presentation will cover the scope, status and results of the surveillance inspections and what they may mean for the future of 21 CFR Part 11. At the beginning of the initiative FDA made it very clear that Part 11 is in effect and is enforced according to the original Part 11 and the Guidance from 2003.

In the meantime FDA officials reported about key findings. For example, George Smith who heads up FDA's Part 11 working group gave an update with examples of violations. This webinar will enable you to determine whether your company is subject to the most common violations so you can take action to have a better inspection outcome.

Areas Covered in the Session :
    • What is FDA's most current thinking related to computers and electronic records?
    • What are the inspection trends?
    • What are most frequent recent citations for Part11?
    • What are the most frequent deviations for computer system validation?
    • Under which circumstances can inspectors exercise enforcement discretion?
    • How important is risk based Part11 compliance?
    • What is the best strategy for future proven Part 11 compliance?
    Who Will Benefit: 
    • Quality Managers
    • Quality Engineers
    • Small business owners
    • GxP
    • Regulatory Affairs professionals
    • Consultants
    • Quality VPs
    • IT VPs
    • Regulatory VP
    • CEOs
    Speaker Profile
    Angela Bazigos is the CEO of Touchstone Technologies Silicon Valley, Inc. “Your Passport to Compliance”. She has 30 years of experience in the Life sciences industry spanning Project Management, Quality Assurance and Regulatory Affairs and has a patent aimed at speeding up Software Compliance. Ms. Bazigos is the president of PRCSQA (Pacific Regional Chapter of the Society of Quality Assurance) a member of the SQA CVIC (Society of Quality Assurance Computer Validation Initiative Committee), ASQ, DIA and RAPS and consults to Pharma / Biotech / Medical Device companies as well as investment groups on compliance matters, including strategy, submissions, quality assurance and remediations following action by the FDA. She teaches classes on Compliance, 21 CFR 11, Computer Systems Validation, and Project Management both to investor groups and industry. More recently, Ms. Bazigos co-authored Computerized Systems in Clinical Research / Current Data Quality and Data Integrity Concepts with FDA, DIA and Academia. She is on the board for UC Berkeley’s Business School for Executive Education in Life Sciences and on the Stanford Who’s Who Registry for contributions to the Life science industry

    1 comment:

    1. Hey,The Agency (FDA) will be leading an arrangement of examinations in an exertion to assess industry's consistence and understanding of Part 11 in light of the requirement attentiveness portrayed in the August 2003 'Part 11, Electronic Records; Electronic Signatures — Scope and Application' (Guidance). The Agency means to make suitable move to uphold Part 11 prerequisites for issues raised throughout the examinations that don't fall under the implementation caution examined in the Guidanc.Thank you so much!!
      >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
      medical device development

      ReplyDelete